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Metabolic syndrome, diabetes and other cardiovascular
risk factors are highly prevalent in people with schizo-
phrenia. Patients are at risk for premature mortality and
overall have limited access to physical health care. In
part these cardio-metabolic risk factors are attributable
to unhealthy lifestyle, including poor diet, high rates of
smoking and sedentary behaviour. But over recent years
it has become apparent that antipsychotic agents can
have a negative impact on some of the modifiable risk
factors. The psychiatrist needs to be aware of the poten-
tial metabolic side effects of antipsychotic medication
and to include them in the risk/benefit assessment when
choosing a specific antipsychotic. He should also be
responsible for the implementation of the necessary
screening assessments and referral for treatment of any
physical illness. Multidisciplinary assessment of psychia-
tric and medical conditions is needed. The somatic
treatments offered to people with severe and enduring
mental illness should be at par with general health care
in the non-psychiatrically ill population.
The recently published joint recommendations of
EPA, EASD and ESC on diabetes and cardiovascular risk
in patients with severe mental disorders should be
implemented in all mental health services.
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